Tag Archives: Ryan Zimmerman

Intuitive Surgical (ISRG) Receives a Hold from BTIG

BTIG analyst Ryan Zimmerman maintained a Hold rating on Intuitive Surgical (ISRG – Research Report) yesterday. The company’s shares closed last Thursday at $741.00, close to its 52-week high of $778.83. According to TipRanks.com, Zimmerman is a 5-star analyst with

BTIG Sticks to Their Buy Rating for Misonix (MSON)

BTIG analyst Ryan Zimmerman maintained a Buy rating on Misonix (MSON – Research Report) today and set a price target of $18.00. The company’s shares closed last Monday at $11.57. According to TipRanks.com, Zimmerman is a 5-star analyst with an

Analysts Offer Insights on Healthcare Companies: Penumbra (NYSE: PEN) and Hill-Rom (NYSE: HRC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Penumbra (PEN – Research Report) and Hill-Rom (HRC – Research Report) with bullish sentiments. Penumbra (PEN) Penumbra received a Buy rating and

BTIG Maintains Their Hold Rating on Intuitive Surgical (ISRG)

BTIG analyst Ryan Zimmerman maintained a Hold rating on Intuitive Surgical (ISRG – Research Report) today. The company’s shares closed last Monday at $716.34, close to its 52-week high of $778.83. According to TipRanks.com, Zimmerman is a 5-star analyst with

Vericel (VCEL) Receives a Buy from BTIG

BTIG analyst Ryan Zimmerman maintained a Buy rating on Vericel (VCEL – Research Report) yesterday and set a price target of $21.00. The company’s shares closed last Tuesday at $15.88. According to TipRanks.com, Zimmerman is a 5-star analyst with an

BTIG Maintains Their Hold Rating on Staar Surgical Company (STAA)

BTIG analyst Ryan Zimmerman maintained a Hold rating on Staar Surgical Company (STAA – Research Report) on August 17. The company’s shares closed last Thursday at $45.99. According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of